← Leaderboards
Girgis Obaid
Massachusetts General Hospital
$2,207,888
Attributed
$2,207,888
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $640.1K · FY2018–25$1M$750K$500K$250K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,207,888 · 3
By mechanism
R01$1,129,001 · 1
R00$720,504 · 1
K99$358,383 · 1
Top collaborators
No co-investigators on record.
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Tayyaba Hasan$21,611,486
- Michael R Hamblin$6,140,037
- Tianhong Dai$5,096,106
- Karl Elmo Anderson$6,471,926
- Amy Kathryn Dickey$1,684,361
Others in their field
Other Emerging Leaders on “Molecular Imaging”
- Leonard Freedman · Leidos Biomedical Research, Inc.$312,047,727
- Lynn Briscoe · Leidos Biomedical Research, Inc.$116,524,368
- Leonard Freedmand · Leidos Biomedical Research, Inc.$67,401,321
- Ross D McDonald · Florida State University$26,502,247
- Michael W Rabin · Florida State University$26,502,247
- Eric C Palm · Florida State University$26,502,247
Research focus
Molecular ImagingSuccessImproved OutcomeModalityResponseSpecificityEnvironmentHeterogeneityIn VivoMalignant NeoplasmsOperative Surgical ProceduresReceptorBindingSpatiotemporalComplexEngineeringEpidermal Growth Factor ReceptorFailureInnovationIn VitroLightLiposomesNanomedicineTumor
Grant awards (7)
Molecular Imaging Guidance for Potentiating Chemoimmunotherapy in Pancreatic Cancer using Photodynamic Priming$488,912
R01 · FY2025 · EB · contact PI
Molecular Imaging Guidance for Potentiating Chemoimmunotherapy in Pancreatic Cancer using Photodynamic Priming$640,089
R01 · FY2024 · EB · contact PI
Molecular imaging-directed bioengineering of nanoconjugates as adaptable tumor targeting platforms$227,477
R00 · FY2022 · CA · contact PI
Molecular imaging-directed bioengineering of nanoconjugates as adaptable tumor targeting platforms$244,410
R00 · FY2021 · CA · contact PI
Molecular imaging-directed bioengineering of nanoconjugates as adaptable tumor targeting platforms$248,617
R00 · FY2020 · CA · contact PI
Molecular imaging-directed bioengineering of nanoconjugates as adaptable tumor targeting platforms$179,103
K99 · FY2019 · CA · contact PI
Molecular imaging-directed bioengineering of nanoconjugates as adaptable tumor targeting platforms$179,280
K99 · FY2018 · CA · contact PI